Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?

Nat Clin Pract Neurol. 2006 Mar;2(3):132-3. doi: 10.1038/ncpneuro0129.
No abstract available

MeSH terms

  • Aged
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Cohort Studies
  • Dementia / complications
  • Humans
  • Ontario / epidemiology
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / epidemiology*
  • Retrospective Studies
  • Risk

Substances

  • Antipsychotic Agents